...
首页> 外文期刊>Frontiers in Microbiology >Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran
【24h】

Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran

机译:耐碳青霉烯类耐药性鲍曼不动杆菌在伊朗烧伤患者中广泛分布

获取原文
           

摘要

Antimicrobial resistance in carbapenem non-susceptible Acinetobacter baumannii (CNSAb) is a major public health concern globally. This study determined the antibiotic resistance and molecular epidemiology of CNSAb isolates from a referral burn center in Tehran, Iran. Sixty-nine CNSAb isolates were tested for susceptibility to antimicrobial agents using the E test methodology. Multiple locus variable number tandem repeat analysis (MLVA), Multilocus sequence typing (MLST) and multiplex PCR were performed. PCR assays tested for ambler classes A, B, and D β-lactamases. Detection of IS Aba 1, characterization of integrons, and biofilm formation were investigated. Fifty-three (77%) isolates revealed XDR phenotypes. High prevalence of bla _(OXA-23)-like (88%) and bla _(PER-1)(54%) were detected. IS Aba 1 was detected upstream of bla _(ADC), bla _(OXA-23)-like and bla _(OXA51)-like genes in, 97, 42, and 26% of isolates, respectively. Thirty-one (45%) isolates were assigned to international clone (IC) variants. MLVA identified 56 distinct types with six clusters and 53 singleton genotypes. Forty previously known MLST sequence types forming 5 clonal complexes were identified. The Class 1 integron (class 1 integrons) gene was identified in 84% of the isolates. The most prevalent (33%) cassette combination was aac A4- cat B8- aad A1. The IC variants were predominant in the A. baumannii lineage with the ability to form strong biofilms. The XDR-CNSAb from burned patients in Iran is resistant to various antimicrobials, including tigecycline. This study shows wide genetic diversity in CNSAb. Integrating the new Iranian A. baumannii IC variants into the epidemiologic clonal and susceptibility profile databases can help effective global control measures against the XDR-CNSAb pandemic.
机译:碳青霉烯类不敏感鲍曼不动杆菌(CNSAb)的抗药性是全球主要的公共卫生问题。这项研究确定了伊朗德黑兰转诊烧伤中心的CNSAb分离株的抗生素耐药性和分子流行病学。使用E测试方法测试了69株CNSAb分离株对抗菌剂的敏感性。进行了多基因座可变数目串联重复分析(MLVA),多基因座序列分型(MLST)和多重PCR。 PCR检测试剂盒A,B和D类β-内酰胺酶。研究了IS Aba 1的检测,整合素的表征以及生物膜的形成。 53(77%)个分离株显示XDR表型。检测到高水平的bla _(OXA-23)样(88%)和bla _(PER-1)(54%)。分别在97%,42%和26%的分离物中检测到bla _(ADC),bla _(OXA-23)样和bla _(OXA51)样基因上游的IS Aba 1。将31个(45%)分离株分配给国际克隆(IC)变体。 MLVA鉴定出56种不同的类型,具有6个簇和53种单基因型。鉴定了形成5个克隆复合物的40种先前已知的MLST序列类型。在84%的分离物中鉴定出1类整合子(1类整合子)基因。最普遍的(33%)盒带组合是aac A4- cat B8-ada A1。 IC变体在鲍曼不动杆菌谱系中占主导地位,并具有形成牢固的生物膜的能力。来自伊朗烧伤患者的XDR-CNSAb对包括替加环素在内的各种抗菌药物具有抗性。这项研究表明CNSAb具有广泛的遗传多样性。将新的伊朗鲍曼不动杆菌IC变异体整合到流行病学克隆和药敏谱数据库中,可以帮助针对XDR-CNSAb大流行采取有效的全球控制措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号